AFP, a classical hepatocellular proliferation marker, paradoxically shows elevated levels in non-responsive patients, suggesting that despite active proliferative status, these tumor cells possess mechanisms enabling survival under TACE-mediated ischemic stress and chemotherapeutic cytotoxicity, thereby evading apoptosis and manifesting treatment refractoriness. This evidence concerns the gene AFP and neoplasm.